• Earlier this month, Putnam BDC Income ETF (PBDC) cut its quarterly distribution by 14% to a record low, citing earnings pressure across its business development company holdings.
• Because Blue Owl Capital is a major PBDC holding with thin earnings coverage and significant floating-rate loan exposure, the move has sharpened investor focus on the resilience of its own dividend profile.
• We’ll now examine how concerns about Blue Owl’s dividend durability and floating-rate loan exposure intersect with its existing long-term growth narrative.

Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

Blue Owl Capital Investment Narrative Recap

To own Blue Owl Capital, you need to believe its permanent capital model and demand for private credit and real assets can offset earnings volatility and high leverage. The recent PBDC distribution cut heightens attention on Blue Owl’s dividend coverage and floating rate exposure, but it does not obviously change the main near term catalyst, which remains sentiment around fee based AUM growth, nor the key risk of pressure on margins and distributions if earnings remain thin.

The most relevant recent announcement here is Blue Owl’s decision on February 5, 2026 to hold its quarterly dividend at US$0.225 per Class A share. That affirmation, coming alongside modest full year 2025 net income of US$78.83 million and a high payout ratio, frames the current debate: can Blue Owl keep funding this dividend from fee related earnings if lower floating rate income persists and fundraising slows, or will distribution expectations need to reset?

But while the dividend has held steady so far, investors should be aware that...

Blue Owl Capital's narrative projects $3.8 billion revenue and $1.0 billion earnings by 2029. This requires 9.6% yearly revenue growth and about an $921 million earnings increase from $78.8 million today.

Uncover how Blue Owl Capital's forecasts yield a $14.93 fair value, a 51% upside to its current price.

Exploring Other Perspectives

Some of the lowest analysts were already more cautious, expecting revenue of about US$3.5 billion and earnings near US$1.0 billion by 2029, and now see dividend pressure and fee compression as signs that fundraising and margins could prove much weaker than the consensus story suggests, so it is worth weighing how this new stress on floating rate income might shift those more pessimistic views.

Explore 9 other fair value estimates on Blue Owl Capital - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Blue Owl Capital research is our analysis highlighting 1 key reward and 4 important warning signs that could impact your investment decision.
• Our free Blue Owl Capital research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Blue Owl Capital's overall financial health at a glance.

Seeking Other Investments?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• Uncover the next big thing with 26 elite penny stocks that balance risk and reward.
• Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.